Loading provider…
Loading provider…
Radiation Oncology Physician in Grand Forks, ND
NPI: 1427252014Primary Practice Location
ALTRU HOSPITAL
1200 S Columbia Rd, Grand Forks, ND
Primary Employer
Altru 1300 Columbia
altru.org
HQ Phone
Get M.D. Grant's Phone Numberphone_androidMobile
Get M.D. Grant's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardMN State Medical License
ND State Medical License
TX State Medical License
CA State Medical License
MI State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 175 | 262 |
| 2 | 77300Calculation of radiation therapy dose | 153 | 267 |
| 3 | 99205New patient office or other outpatient visit, typically 60 minutes | 132 | 132 |
| 4 | 77014Ct scan guidance for insertion of radiation therapy fields | 128 | 2,131 |
| 5 | 77427Radiation treatment management, 5 treatment sessions | 114 | 361 |
N-Acetylcysteine Rinse for Thick Secretion and Mucositis of Head and Neck Chemoradiotherapy (Alliance MC13C2): A Double-Blind Randomized Clinical Trial.
Authors: Miran Blanchard, Robert Foote, Lisa Mcgee, Yolanda Garces, Jean-Claude Rwigema, Michelle Neben Wittich
Publication Date: 2018-08-28
Authors: Daniel Petereit, Charles Loprinzi, Rex Mowat
Journal: Int J Radiat Oncol Biol Phys
Publication Date: 2016-04-23
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: DRUG: Temozolomide, OTHER: Laboratory Biomarker Analysis, OTHER: Quality-of-Life Assessment, DRUG: Veliparib, OTHER: Placebo Administration
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: PROCEDURE: Magnetic Resonance Imaging, OTHER: Questionnaire Administration, BIOLOGICAL: Nivolumab, BIOLOGICAL: Ipilimumab, PROCEDURE: Biospecimen Collection, OTHER: Quality-of-Life Assessment, DRUG: Cabozantinib, PROCEDURE: Computed Tomography, PROCEDURE: Bone Scan
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: PROCEDURE: Magnetic Resonance Imaging, BIOLOGICAL: Pembrolizumab, PROCEDURE: Positron Emission Tomography, PROCEDURE: Biospecimen Collection, RADIATION: Radiation Therapy, OTHER: Best Practice, PROCEDURE: Computed Tomography